REFERENCES
- Brawn PN, Speights VOThe dedifferentiation of metastatic prostate carcinomaBr J Cancer 1989; 59: 85–88.
- Chybowski FM, Larson Keller JJ, Bergstralh EJ, Oesterling JEPredicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: Prostate specific antigen is superior to all other clinical parametersJ Urol 1991; 145: 313–318.
- Crawford EDHormonal therapy of prostatic carcinoma. Defining the challengeCancer 1990; 66: 1035–1038.
- Grayhack JT, Keeler TC, Kozlowski JMCarcinoma of the prostate. Hormonal therapyCancer 1987; 60: 589–601.
- Hetherington JW, Siddall JK, Cooper EHContribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancerEur Urol 1988; 14: 1–5.
- Huggins C, Hodges CVStudies on prostatic cancer. 1. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostateCancer Res 1941; 1: 293–297.
- Matzkin H, Perito PE, Soloway MSPrognostic factors in metastatic prostate cancerCancer 1993; 72: 3788–3792.
- Smith JAJrNew methods of endocrine management of prostatic cancerJ Urol 1987; 137: 1–10.
- Snedecor GW, Cochran WGStatistical methods 7th ed.Iowa State University PressAmes, Iowa1980.
- Soloway MSThe importance of prognostic factors in advanced prostate cancerCancer 1990; 66: 1017–1021.
- Sundkvist GMG, Ahlgren L, Lilja B, Mattsson S, Abrahamsson PA, Wadström LBRepeated quantitative bone scintigraphy in patients with prostatic carcinoma treated with orchiectomyEur J Nucl Med 1988; 14: 203–206.
- Sundkvist GMG, Ahlgren L, Lilja B, Mattsson S, Abrahamsson PADynamic quantitative bone scintigraphy in patients with prostatic carcinoma treated by orchiectomyEur J Nucl Med 1990; 16: 671–676.
- Sundkvist GMG, Ahlgren L, Lilja B, Mattsson SAdditional information from quantitative 24-hour 99mTc-MDP bone scintigraphy in patients with prostatic carcinomaActa Oncol 1991; 30: 635–639.
- Sundkvist GMGQuantitative bone scintigraphy. A study in patients with prostatic carcinoma1991 Thesis, Malmö..
- Sundkvist GMG, Ahlgren L, Lilja B, Mattsson SQuantitative bone scintigraphy and 24-hour whole-body counting of 99mTc-methylene diphosphonate in patients with prostatic carcinomaNucl Med 1992; 31: 178–181.
- Sundkvist GMG, Ahlgren L, Lilja B, Mattsson SQuantitative bone scintigraphy in prostatic carcinoma — long-term response to treatmentNucl Med 1993; 32: 231–235.
- Wang MC, Valenzuela LA, Murphy GP, Chu TMPurification of a human prostate specific antigenInvest Urol 1979; 17: 159–163.